NOVAROCK BIOTHERAPEUTICS Trademark

Trademark Overview

On Wednesday, April 25, 2018, a trademark application was filed for NOVAROCK BIOTHERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the NOVAROCK BIOTHERAPEUTICS trademark a serial number of 87892684. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 10, 2022. This trademark is owned by NovaRock Biotherapeutics, Ltd.. The NOVAROCK BIOTHERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Biotherapeutic preparations, namely, monoclonal antibodies for use in the treatment of cancer, hematological disorders,solid tumors and autoimmune disorders
novarock biotherapeutics

General Information

Serial Number87892684
Word MarkNOVAROCK BIOTHERAPEUTICS
Filing DateWednesday, April 25, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 10, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 9, 2019

Trademark Statements

Indication of Colors claimedThe color(s) Black and aqua blue is/areclaimed as a feature of the mark.
Disclaimer with Predetermined Text"BIOTHERAPEUTICS"
Description of MarkThe mark consists of the wording "NOVAROCK" in black lettering where the letters "N" and "R" are capitalized with the wording "BIOTHERAPEUTICS" underneath in smaller uppercase lettering. The letter "V" and the letter "I" are replaced with an aqua blue antibody symbol.
Goods and ServicesBiotherapeutic preparations, namely, monoclonal antibodies for use in the treatment of cancer, hematological disorders,solid tumors and autoimmune disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 4, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovaRock Biotherapeutics, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEwing, NJ 08628
Party NameNovaRock Biotherapeutics, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressEwing, NJ 08628
Party NameNovaRock Biotherapeutics, Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMonmouth Junction, NJ 08852

Trademark Events

Event DateEvent Description
Monday, January 10, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 10, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 1, 2021EXTENSION 4 GRANTED
Tuesday, June 1, 2021EXTENSION 4 FILED
Tuesday, June 1, 2021TEAS EXTENSION RECEIVED
Tuesday, April 13, 2021CORRECTED NOA E-MAILED
Monday, April 12, 2021NOTICE OF ALLOWANCE CORRECTION ENTERED
Monday, April 12, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 2, 2021TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, November 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 23, 2020EXTENSION 3 GRANTED
Monday, November 23, 2020EXTENSION 3 FILED
Monday, November 23, 2020TEAS EXTENSION RECEIVED
Friday, June 5, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 5, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 5, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 1, 2020EXTENSION 2 GRANTED
Monday, June 1, 2020EXTENSION 2 FILED
Monday, June 1, 2020TEAS EXTENSION RECEIVED
Thursday, December 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 3, 2019EXTENSION 1 GRANTED
Tuesday, December 3, 2019EXTENSION 1 FILED
Tuesday, December 3, 2019TEAS EXTENSION RECEIVED
Tuesday, June 4, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 10, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 10, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 9, 2019PUBLISHED FOR OPPOSITION
Wednesday, March 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, March 2, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 2, 2019EXAMINER'S AMENDMENT ENTERED
Saturday, March 2, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, March 2, 2019EXAMINERS AMENDMENT E-MAILED
Saturday, March 2, 2019EXAMINERS AMENDMENT -WRITTEN
Friday, October 12, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 12, 2018NON-FINAL ACTION E-MAILED
Friday, October 12, 2018NON-FINAL ACTION WRITTEN
Wednesday, September 12, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 12, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 11, 2018ASSIGNED TO LIE
Tuesday, August 28, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 28, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 27, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 27, 2018NON-FINAL ACTION E-MAILED
Monday, August 27, 2018NON-FINAL ACTION WRITTEN
Thursday, August 16, 2018ASSIGNED TO EXAMINER
Friday, May 4, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 28, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

biotherapeutics novarock disorders hematological solid tumors autoimmune cancer treatment preparations namely monoclonal